中国上海，2024年10月8日 — 全球化的合同研究、开发和生产公司（CRDMO）保诺-桑迪亚宣布，其位于上海外高桥研发中心的新化合物管理中心正式启用。新增的化合物管理中心可以系统化地存储、处理和管理化合物，将进一步增强公司的综合药物发现能力。
化合物管理中心设有化合物存储实验室，配置实时温湿度控制系统，可管理超过40万种固体和液体化合物。主要服务包括存储、称重、溶解、铺板、LC-MS分析和配送。该中心还配备了汉密尔顿液体处理站，可实现工作流程的全自动化，并与 Mosaic 样品管理软件集成，用于追踪和管理样品生命周期中的每一个步骤。
该中心的先进设备可确保客户的化合物得到安全存储，并精确跟踪和实时更新库存，样品可随取随用并快速交付，让客户没有后顾之忧。结合公司现有的药物发现整合服务，新增的化合物管理中心可以帮助客户加快研发进程，降低研发成本，加速新兴疗法的探索发现。
苏一名（Armin Spura）博士，首席执行官
保诺-桑迪亚首席执行官苏一名（Armin Spura）博士表示：“我们新的化合物管理中心正式运营，标志着我们在提供全球化药物研发服务方面又迈出了重要一步。通过将这一前沿的化合物管理系统与我们的药物研发平台相结合，我们可以为客户提供更快、更可靠的解决方案，将他们的候选新药快速推向市场，造福全球患者。”
关于保诺-桑迪亚
保诺-桑迪亚，安宏资本旗下投资企业，拥有28年的历史，是一家值得信赖的全球化合同研究、开发和生产公司（CRDMO）。公司总部位于加州尔湾，在中国和美国设有7个研发生产中心，在全球拥有2000多名员工。我们专注于小分子和大分子的药物发现、开发、放大和生产服务，为生物技术和制药企业提供从早期靶点确证到商业化生产的整合服务，涵盖化学、生物学、药代动力学、原料药和成品药等多个领域。保诺-桑迪亚专注CRDMO服务，在全球化质量标准体系下运营，提供先进、快速和灵活的定制服务，以满足生物技术和制药企业的专属需求，加快新药开发进程。
更多信息，请访问公司官网https://www.bioduro-sundia.cn
BioDuro-Sundia Launches New Compound Management Center, Strengthening Drug Discovery Services
IRVINE, CALIF., October 8, 2024 – BioDuro-Sundia, a leading global contract research, development and manufacturing organization (CRDMO), today announced the launch of a new Compound Management Center at its Waigaoqiao site in the Shanghai Free-Trade Zone, China. This new center enables the systematic storage, handling, and management of compounds, further enhancing the company's comprehensive drug discovery capabilities.
The center features a compound storage laboratory equipped with real-time temperature and humidity control systems, which can manage approximately 400,000 compounds in both solid and liquid formats. Key services include storage, weighing, dissolution, plating, liquid chromatography–mass spectrometry (LC–MS) analysis, and distribution. The center is also equipped with a Hamilton liquid handling station for fully automated workflows, and the Mosaic sample management software to track and manage steps in each sample's lifecycle.This state-of-the-art center offers customers peace of mind by ensuring that their compounds are securely stored, their inventories are meticulously tracked and updated in real-time, and their samples are readily accessible for quick delivery. When combined with the company's established drug discovery services on-site, the new facility will enable clients to expedite their research and development processes, reducing costs and accelerating the discovery of new candidate therapies."Our new Compound Management Center represents a significant step forward in our commitment to providing world-class drug discovery services," said Dr. Armin Spura, CEO of BioDuro-Sundia. "By integrating this cutting-edge compound management system with our drug discovery platform, we can offer our clients faster, more reliable solutions to bring their new drug candidates to market, benefiting patients around the world."BioDuro-Sundia, an Advent International portfolio company, is a trusted, leading contract research, development, and manufacturing organization (CRDMO) with a 28-year proven track record. Headquartered in Irvine, California, USA, our global presence spans 7 sites across the United States and China, with over 2,000 employees. Specializing in both small and large molecule discovery, development, scale-up, and manufacturing, we offer fully integrated services from early drug discovery to commercial manufacturing across chemistry, biology, DMPK, drug substance, and drug product. Dedicated to our integrated CRDMO platform, BioDuro-Sundia operates under a single global standard, delivering fast, integrated, and customized services to meet the unique needs of our clients worldwide.For more information, please visit https://www.bioduro-sundia.com北京 | 上海 | 无锡 | 河北 | 尔湾 | 蚌埠
从原料药到药品，从发现到开发，从小分子到生物制剂，保诺-桑迪亚是您的合作伙伴，可加快您的项目并提高候选药物成功的效率。
• 保诺-桑迪亚任命 Armin Spura 博士为首席执行官｜Bilingual
2026-03-01
20页
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
收藏
登录后参与评论
暂无评论